Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Coronavirus Update: Oxford Racing Ahead With 8,000 Vaccinated In Phase III Trial
Plus: Eisai Joins RE-MAP Cap Study
Jul 02 2020
•
By
Scrip Team
Oxford, UK: The trials led by the university's Jenner Institute have already vaccinated 8,000 subjects
More from COVID-19
More from Scrip